Skip to main content

Collegium Pharmaceutical

Published

Oct 23, 2025

Vikram Karnani, CEO of Collegium Pharmaceutical (NSDQ: COLL), sits down with Nasdaq’s Kristina Ayanian to discuss the company’s 10-year anniversary as a publicly traded firm. He shares insights on Collegium’s growth, impact on the ADHD community, and what investors can expect as the company looks ahead to 2026 and beyond.

No transcript available

My Quotes
My European Quotes
Watchlist

View as Table

now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing Stocks, Funds, ETFs and more asset classes.

/

View as Table

now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing Shares, Indexes, ETP and more asset classes.

/

Edit Watchlist

Your Watchlist is empty.

Create your Watchlist to save your favorite quotes on Nasdaq.com. Log in or create a free account to get started.

/